Hou et al. have developed a glycopeptide-based nano-activator that, upon exposure of the serine binding site by the tumor-overexpressed enzyme O-GlcNAcase (OGA), transforms from a spherical to a fibrous shape. This evidence concerns the gene OGA and neoplasm.